Incidence of p14(arf) gene deletion in high-grade adult and pediatric astrocytomas

Human Pathology

Volumn 31, Issue 1, 2000, Pages 115-119

  Newcomb, Elizabeth W ^a   Alonso, Michelle ^a   Sung, Tammy ^a   Miller, Douglas C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytoma; Glioblastoma; INK4a ARF locus; p14(ARF); p16(INK4a)

Indexed keywords

CELL CYCLE PROTEIN; CARRIER PROTEIN; PROTEIN; PROTEIN P14ARF; PROTEIN P16INK4A;

ADULT; ARTICLE; ASTROCYTOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INCIDENCE; CANCER STAGING; CELL CYCLE; CHILD; DISEASE ASSOCIATION; ENZYME ACTIVITY; EXON; GENE EXPRESSION; GENE LOCUS; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; CELL CULTURE; GENE DELETION; GENETICS; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PRESCHOOL CHILD;

ADULT; ASTROCYTOMA; CARRIER PROTEINS; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE DELETION; GLIOBLASTOMA; GLIOMA; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0033622180     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(00)80207-5     Document Type: Article

References (41)

1. James CD He J Carlbom E Chromosome 9 deletion mapping reveals interferon α and interferon β-1 deletions in human glial tumors Cancer Res 51 1991 1684 1688
2. Olopade OI Jenkins RB Ransom DT Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas Cancer Res 52 1992 2523 2529
3. Bello MJ de Campos JM Vaquero J Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas Genes Chromosomes Cancer 9 1994 33 41
4. Dreyling MH Bohlander SK Adeyanju MO Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization Cancer Res 55 1995 984 988
5. Kamb A Gruis NA Weaver-Feldhaus J A cell cycle regulator potentially involved in genesis of many tumor types Science 264 1994 436 440
6. Cairns P Mao L Merlo A Rates of p16 (MTS1) mutations in primary tumors with 9p loss Science 265 1994 415 416
7. INK4A genes in astrocytomas Diagn Mol Pathol 6 1997 115 122
8. Burns KL Ueki K Jhung SL Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas J Neuropathol Exp Neurol 57 1998 122 130
9. INK4 expression is frequent in high grade gliomas Cancer Res 55 1995 1941 1945
10. Merlo A Herman JG Mao L 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers Nature Med 1 1995 686 692
11. Schmidt EE Ichimura K Messerle KR Infrequent methylation of CDKN2A (MTS1/p16) and rare mutation of both CDKN2A and CDKN2B (MTS2/p15) in primary astrocytic tumours Br J Cancer 75 1997 2 8
12. Ueki K Rubio M-P Ramesh V MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p Hum Mol Genet 3 1994 1841 1845
13. Li Y-J Hoang-Xuan K Delattre J-Y Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas Oncogene 11 1995 597 600
14. Moulton T Samara G Chung W-Y MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme Am J Pathol 146 1995 613 619
15. Stone S Jiang P Dayananth P Complex structure and regulation of the p16 (MTS1) locus Cancer Res 55 1995 2988 2994
16. Quelle DE Zindy F Ashmun RA Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest Cell 83 1995 993 1000
17. Arap W Nishikawa R Furnari FB Replacement of the p16/CDK2 gene suppresses human glioma cell growth Cancer Res 55 1995 1351 1354
18. Arap W Knudsen E Sewell DA Functional analysis of wild-type and malignant glioma derived CDKN2Aβ alleles: Evidence for an RB-independent growth suppressive pathway Oncogene 15 1997 2013 2020
19. He J Allen JR Collins VP CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines Cancer Res 54 1994 5804 5807
20. Ueki K Ono Y Henson JW CDKN2/p16 or Rb alterations occur in the majority of glioblastomas and are inversely correlated Cancer Res 56 1996 150 153
21. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53 Cell 92 1998 713 723
22. Wu X Bayle JH Olson D The p53-mdm-2 autoregulatory feedback loop Genes Dev 7 1993 1126 1132
23. Hayashi Y Ueki K Waha A Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme Brain Pathol 7 1997 871 875
24. ARF Cell 91 1997 649 659
25. Serrano M Lee H-W Chin L Role of the INK4a locus in tumor suppression and mortality Cell 85 1996 27 37
26. Jen JJ Harper W Bigner SH Deletion of p16 and p15 genes in brain tumors Cancer Res 54 1994 6353 6358
27. Kleihues P Burger PC Scheithauer BW Histological Typing of Tumors of the Central Nervous System 1993 Springer-Verlag New York, NY
28. Newcomb EW Cohen H Lee SR Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes Brain Pathol 8 1998 655 667
29. Lang FF Miller DC Koslow M Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors J Neurosurg 81 1994 427 436
30. Soong R Iacopetta BJ A rapid and nonisotopic method for screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors Mod Pathol 10 1997 252 258
31. Ono Y Tamiya T Ichikawa T Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices J Neuropathol Exp Neurol 55 1996 1026 1031
32. Hunter SB Abbott K Varma VA Reliability of differential P{CR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue J Neuropathol Exp Neurol 54 1995 57 64
33. Wood DE Thomas A Devi LA Bax cleavage is mediated by calpain during drug-induced apoptosis Oncogene 17 1998 1069 1078
34. Schmidt EE Ichimura K Reifenberger G CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas Cancer Res 54 1994 6321 6324
35. ARF Proc Natl Acad Sci 94 1997 669 673
36. ARF in breast cancer Clinical Cancer Res 2 1996 1993 1998
37. ARF encoding exons in T-cell acute lymphoblastic leukemia Blood 91 1998 1016 1020
38. INK4a gene is frequently lost in small cell lung cancer Cancer Res 58 1998 3926 3931
39. Zhang Y Xiong Y Yarbrough WG ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways Cell 92 1998 725 734
40. Weber JD Taylor LJ Roussel MF Nucleolar Arf sequesters Mdm2 and activates p53 Nature Cell Biol 1 1999 20 26
41. Senderowicz AM Headlee D Stinson SF Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms J Clin Oncol 16 1998 2986 2999